AKBA - Akebia Q2 2023 Earnings Preview
2023-08-24 11:21:09 ET
More on Akebia
- Akebia: 'Hold' Through Regulatory And Financial Hurdles
- Akebia Therapeutics: Take Profits Before Second Quarter Report
- Akebia Therapeutics: Buy This Undervalued Stock At Just 77% Of Revenue
- Akebia plans to resubmit vadadustat NDA by end of Q3
- Akebia to resubmit FDA application for kidney drug by end of Q3
- Akebia settles last patent lawsuit related to kidney disease therapy
- Akebia jumps 16% as Piper upgrades after updates on kidney disease candidate
- Seeking Alpha’s Quant Rating on Akebia
- Earnings data for Akebia
For further details see:
Akebia Q2 2023 Earnings Preview